Millions of scars are formed annually with wide-ranging effects on the quality of life of the individual. Currently, there is no internationally validated, rigorously tested PRO measure ('PROM') that can be used to assess scar outcomes of all major etiologies in both children and adults. Nor, do we currently understand why patients may seek scar revision surgery. The purpose of this study is to describe the international field-test of seven clinics in four countries, the psychometric properties of the PROM, and the independent risk factors of patients requiring scar revision surgery.
METHODS:
Between March, 2017 and April, 2018 data were collected from 7 outpatient clinics in New Zealand, Chile, Canada, and the USA. Participants completed a questionnaire booklet with demographic and clinical questions as well as the preliminary SCAR-Q (Appearance, Symptom, and Psychosocial Impact). Rasch Measurement Theory (RMT) analysis was conducted examining item response options, item fit statistics, dependency, targeting, stability, and person separation index. In addition, Cronbach's alpha and intraclass correlation coefficient were completed to examine reliability. In addition, a multivariable regression analysis was completed to examine independent risk factors for patients self-reporting the need for scar revision surgery. (OR 2.631, ), a prior scar revision surgery (0.253; 0.127-0.672), and scoring poorly on the SCAR-Q Psychosocial Impact scale (OR 0.339; 0.171-0.672) were independent risk factors for reporting the need for future scar revision surgery.
RESULTS

CONCLUSION:
This RMT analysis showed that the 3 SCAR-Q scales performed well in this international, fieldtest sample, with good to excellent reliability. The SCAR-Q represents a rigorously developed PROM that can be used to evaluate scars in research, clinical care, and quality improvement initiatives. In addition, this study suggests that patients with the listed independent risk factors may require heightened attention and clinical care. These individuals may require more scar symptom management, psychosocial support in the case of social work or in severe cases a psychiatry referral, and/or scar treatment to help alleviate their appearance related concerns.
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The Use of Ultrasound Guidance for the treatment of Raynaud's Disease of the Hand with Botulinum Toxin landmark-based surface anatomy approach. The present study sought to examine the feasibility and effectiveness of the use of ultrasound as a clinical adjunct in the delivery of Botulinum Toxin for the treatment of Raynaud's phenomenon of the hand.
METHODS:
For the anatomic feasibility study, cadaveric elbow-to fingertip specimens were injected with dye using either a landmark-based surface anatomy approach or using ultrasound guidance to specifically target the common digital arteries. The specimens were dissected and areas of distribution of the dye at the levels of the neurovascular bundles and intrinsic muscles of the hand were objectively analyzed using Image J (National Institutes of Health).
For the clinical efficacy of ultrasound-guided delivery, three patients diagnosed with Raynaud's Disease of the hand who had failed other non-surgical interventions were treated with Botulinum Toxin using ultrasound guidance.
Demographic information, co-morbidities, and PatientReported Outcomes Measurement Information System (PROMIS) Upper Extremity (United States Department of Health and Human Services) were collected.
RESULTS:
The cadaver hand injected with dye using the traditional landmark-based approach demonstrated significantly increased infiltration of the intrinsic muscles of the hand compared to the cadaver hand injected using ultrasound guidance.
The area of vasculature that were infiltrated with the dye was not statistically different between the two techniques.
All three patients treated with Botulinum Toxin using ultrasound guidance reported improvement in symptoms and function after injection (PROMIS Upper Extremity T score pre-injection mean 29.2, post-injection mean 37) and zero patients reported intrinsic hand weakness.
CONCLUSION:
Ultrasound guided injection of a simulation material dye was significantly more accurate in this anatomical study for targeting the vasculature and avoiding the intrinsic muscles of the hand. Ultrasound guidance was practicable in the clinic setting for the delivery of Botulinum Toxin for treatment of vasospastic disease of the hand with no hand weakness reported in this study. Further studies are required to characterize the apparent risk reduction using ultrasound guidance and to demonstrate cost effectiveness. 
